Raymond James & Associates’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-22,207
| Closed | -$448K | – | 4137 |
|
|
2021
Q3 | $448K | Sell |
22,207
-13,628
| -38% | -$275K | ﹤0.01% | 3131 |
|
|
2021
Q2 | $1.34M | Buy |
35,835
+6,563
| +22% | +$245K | ﹤0.01% | 2387 |
|
|
2021
Q1 | $748K | Buy |
29,272
+7,148
| +32% | +$183K | ﹤0.01% | 2701 |
|
|
2020
Q4 | $487K | Sell |
22,124
-371
| -2% | -$8.17K | ﹤0.01% | 2810 |
|
|
2020
Q3 | $405K | Buy |
22,495
+17
| +0.1% | +$306 | ﹤0.01% | 2760 |
|
|
2020
Q2 | $571K | Sell |
22,478
-155
| -0.7% | -$3.94K | ﹤0.01% | 2492 |
|
|
2020
Q1 | $416K | Sell |
22,633
-1,978
| -8% | -$36.4K | ﹤0.01% | 2537 |
|
|
2019
Q4 | $542K | Buy |
24,611
+165
| +0.7% | +$3.63K | ﹤0.01% | 2657 |
|
|
2019
Q3 | $351K | Buy |
+24,446
| New | +$351K | ﹤0.01% | 2893 |
|